These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36871242)

  • 21. Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics.
    Ulldemolins M; Roberts JA; Wallis SC; Rello J; Lipman J
    J Antimicrob Chemother; 2010 Aug; 65(8):1771-8. PubMed ID: 20530507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total flucloxacillin plasma concentrations poorly reflect unbound concentrations in hospitalized patients with Staphylococcus aureus bacteraemia.
    Chin PKL; Drennan PG; Gardiner SJ; Zhang M; Dalton SC; Chambers ST; Begg EJ
    Br J Clin Pharmacol; 2018 Oct; 84(10):2311-2316. PubMed ID: 29908071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of and maintenance dose recommendations for vancomycin in severe pneumonia patients undergoing continuous venovenous hemofiltration with the combination of predilution and postdilution.
    Li Q; Liang F; Sang L; Li P; Lv B; Tan L; Liu X; Chen W
    Eur J Clin Pharmacol; 2020 Feb; 76(2):211-217. PubMed ID: 31734748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of Calcium Infusion Rate During Continuous Veno-venous Hemofiltration with Regional Citrate Anticoagulation in Critically Ill Patients with Acute Kidney Injury.
    Liu DL; Huang LF; Ma WL; Ding Q; Han Y; Zheng Y; Li WX
    Chin Med J (Engl); 2016 Jul; 129(14):1682-7. PubMed ID: 27411455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial.
    Schilder L; Nurmohamed SA; Bosch FH; Purmer IM; den Boer SS; Kleppe CG; Vervloet MG; Beishuizen A; Girbes AR; Ter Wee PM; Groeneveld AB;
    Crit Care; 2014 Aug; 18(4):472. PubMed ID: 25128022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Customized Citrate Anticoagulation versus No Anticoagulant in Continuous Venovenous Hemofiltration in Critically Ill Patients with Acute Kidney Injury: A Prospective Randomized Controlled Trial.
    Ratanarat R; Phairatwet P; Khansompop S; Naorungroj T
    Blood Purif; 2023; 52(5):455-463. PubMed ID: 36858026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Individualized vancomycin dosing for a patient diagnosed as severe acute pancreatitis with concurrent extracorporeal membrane oxygenation and continuous veno-venous hemofiltration therapy: a case report].
    He N; Yan YY; Ying YQ; Yi M; Yao GQ; Ge QG; Zhai SD
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 50(5):915-920. PubMed ID: 30337758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of renal replacement modalities on the clearance of piperacillin-tazobactam administered via continuous infusion in critically ill patients.
    Roger C; Cotta MO; Muller L; Wallis SC; Lipman J; Lefrant JY; Roberts JA
    Int J Antimicrob Agents; 2017 Aug; 50(2):227-231. PubMed ID: 28689876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration.
    Tiranathanagul K; Jearnsujitwimol O; Susantitaphong P; Kijkriengkraikul N; Leelahavanichkul A; Srisawat N; Praditpornsilpa K; Eiam-Ong S
    Ther Apher Dial; 2011 Dec; 15(6):556-64. PubMed ID: 22107692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Target attainment and population pharmacokinetics of flucloxacillin in critically ill patients: a multicenter study.
    Meenks SD; Punt N; le Noble JLML; Foudraine NA; Neef K; Janssen PKC
    Crit Care; 2023 Mar; 27(1):82. PubMed ID: 36869388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure.
    Level C; Chauveau P; Guisset O; Cazin MC; Lasseur C; Gabinsky C; Winnock S; Montaudon D; Bedry R; Nouts C; Pillet O; Benissan GG; Favarel-Guarrigues JC; Castaing Y
    Crit Care; 2003 Dec; 7(6):R160-6. PubMed ID: 14624691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional Citrate Anticoagulation versus No-Anticoagulation for Continuous Venovenous Hemofiltration in Acute Severe Hypernatremia Patients with Increased Bleeding Risk: A Retrospective Cohort Study.
    Zhao L; Ma F; Yu Y; Li Y; Wang Y; He L; Zhou M; Tian X; Jing R; Li L; Li L; Huang C; Bai M; Sun S
    Blood Purif; 2020; 49(1-2):44-54. PubMed ID: 31522180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simplified regional citrate anticoagulation protocol for CVVH, CVVHDF and SLED focused on the prevention of KRT-related hypophosphatemia while optimizing acid-base balance.
    Di Mario F; Sabatino A; Regolisti G; Pacchiarini MC; Greco P; Maccari C; Vizzini G; Italiano C; Pistolesi V; Morabito S; Fiaccadori E
    Nephrol Dial Transplant; 2023 Sep; 38(10):2298-2309. PubMed ID: 37037771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous venovenous hemofiltration: an alternative to continuous arteriovenous hemofiltration and hemodiafiltration in acute renal failure.
    Macias WL; Mueller BA; Scarim SK; Robinson M; Rudy DW
    Am J Kidney Dis; 1991 Oct; 18(4):451-8. PubMed ID: 1928064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A mode of CVVH with regional citrate anticoagulation compared to no anticoagulation for acute kidney injury patients at high risk of bleeding.
    Gao J; Wang F; Wang Y; Jin D; Tang L; Pan K
    Sci Rep; 2019 Apr; 9(1):6607. PubMed ID: 31036927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of continuous venovenous hemofiltration on neutrophil gelatinase-associated lipocalin plasma levels in patients with septic acute kidney injury.
    Dai X; Li T; Zeng Z; Fu C; Wang S; Cai Y; Chen Z
    BMC Nephrol; 2016 Oct; 17(1):154. PubMed ID: 27760529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V; Garg U; Warady BA; Alon US
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous venovenous hemofiltration with citrate-based replacement fluid: efficacy, safety, and impact on nutrition.
    Bihorac A; Ross EA
    Am J Kidney Dis; 2005 Nov; 46(5):908-18. PubMed ID: 16253732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis.
    Leder K; Turnidge JD; Korman TM; Grayson ML
    J Antimicrob Chemother; 1999 Jan; 43(1):113-8. PubMed ID: 10381108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous-infusion beta-lactam antibiotics during continuous venovenous hemofiltration for the treatment of resistant gram-negative bacteria.
    Moriyama B; Henning SA; Neuhauser MM; Danner RL; Walsh TJ
    Ann Pharmacother; 2009 Jul; 43(7):1324-37. PubMed ID: 19584386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.